Mass Production System for Astatine-211 Presented at WTTC20
Mass Production System for Astatine-211 Presented at WTTC20
News Release
MTC will participate in WTTC20 (The 20th International Workshop on Targetry and Target Chemistry), taking place at Nara Kasugano International Forum IRAKA from August 23 to 27, 2026. MTC will present a poster showcasing its research on a large-scale production system for Astatine-211 (At-211). Astatine-211 is a promising radionuclide for Targeted Alpha Therapy (TAT), an emerging cancer treatment modality. MTC is committed to developing manufacturing technologies to enable the practical application of At-211 in the medical field.
Metal Technology Co. Ltd.
